Skip to main content
. 2023 Mar 4;15(5):1604. doi: 10.3390/cancers15051604

Table 1.

Baseline characteristics of all H. pylori-treated patients.

Characteristics Family History of GC
(n = 294,706)
No Family History of GC
(n = 1,594,109)
p-Value
Age at screening (years) 57.1 ± 9.7 57.1 ± 9.8 <0.001
Age group at screening
 40–49 years 66,376 (22.5) 367,285 (23.0) <0.001
 50–59 years 109,451 (37.1) 579,176 (36.3)
 60–69 years 82,100 (27.9) 440,026 (27.6)
 ≥70 years 36,779 (12.5) 207,622 (13.0)
Sex
 Female 123,644 (42.0) 613,556 (38.5) <0.001
 Male 171,062 (58.0) 980,553 (61.5)
Obesity (BMI ≥ 25 kg/m2)
 No 190,779 (64.7) 1,021,777 (64.1) <0.001
 Yes 103,902 (35.3) 572,168 (35.9)
 Unknown 25 (0.0) 164 (0.0)
Smoking habit
 Never 195,926 (66.5) 1,115,474 (70.0) <0.001
 Former 51,370 (17.4) 232,825 (14.6)
 Current 47,309 (16.1) 245,282 (15.4)
 Unknown 101 (0.0) 528 (0.0)
Alcohol consumption
 0 or 1 time per week 227,576 (77.2) 1,252,957 (78.6) <0.001
 ≥2 times per week 66,897 (22.7) 340,069 (21.3)
 Unknown 233 (0.1) 1083 (0.1)
Physical activity
 No 66,836 (22.7) 394,668 (24.8) <0.001
 Yes (≥1 time per week) 227,552 (77.2) 1,197,894 (75.2)
 Unknown 318 (0.1) 1547 (0.1)
Comorbidities
 Hypertension 80,762 (27.4) 462,299 (29.0) <0.001
 Diabetes mellitus 30,353 (10.3) 170,240 (10.7)
 Dyslipidemia 23,646 (8.0) 120,842 (7.6)
 Ischemic heart disease 11,569 (3.9) 61,131 (3.8)
 Stroke 3656 (1.2) 19,605 (1.2)
Comorbidity status (yes) 108,743 (36.9) 606,308 (38.0) <0.001
Indication for H. pylori eradication
 Gastric ulcer 61,147 (20.7) 320,248 (20.1) <0.001
 Duodenal ulcer 15,229 (5.2) 79,547 (5.0)
 Gastric and duodenal ulcer a 13,469 (4.6) 74,606 (4.7)
 Gastric MALT lymphoma 4 (0.0) 3 (0.0)
H. pylori-associated gastritis 204,857 (69.5) 1,119,705 (70.2)

GC, gastric cancer; BMI, body mass index; H. pylori, Helicobacter pylori; MALT, mucosa-associated lymphoid tissue. Values are presented as mean ± standard deviation or number (%). a Gastric ulcer and duodenal ulcer/ gastroduodenal ulcer unspecified.